Summary
The computed 12-month bankruptcy probability of LDM Pharma is 1.8% (moderate). The company has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. No annual accounts have been filed with the National Bank.
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- LDM Pharma
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Ldmpharma@outlook.be, Sneppestraat 1,8860 Lendelede” (deed in Dutch)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Bepaalde of onbepaalde duur, een of meerdere zaakvoerders” (deed in Dutch)
Meetings and financial year
- Financial yearThe twelve-month period the company draws up its annual accounts for.
- From 1 January to 31 December
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- One provision in the deed